Ivabradine and outcomes in chronic heart failure (SHIFT): A randomised placebo-controlled study

The Lancet

Volumn 376, Issue 9744, 2010, Pages 875-885

  Swedberg, Karl ^a   Komajda, Michel ^b   Böhm, Michael ^c   Borer, Jeffrey S ^d   Ford, Ian ^e   Dubost Brama, Ariane ^f   Lerebours, Guy ^f   Tavazzi, Luigi ^g  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SORBONNE UNIVERSITÉ   (France)

^c SAARLAND UNIVERSITY   (Germany)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

^f IRIS Institut de Recherches Internationales Servier   (France)

^g Research Ettore Sansavini Health Science Foundation   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZAZEPINE DERIVATIVE; CARDIOVASCULAR AGENT; IVABRADINE;

ADULT; AGED; CHRONIC DISEASE; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART RATE; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; SINUS NODE; TREATMENT OUTCOME;

ADULT; AGED; BENZAZEPINES; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART RATE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SINOATRIAL NODE; TREATMENT OUTCOME;

EID: 77956612624     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61198-1     Document Type: Article

References (26)

1. K Dickstein, A Cohen-Solal, G Filippatos ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 2008 933 989
2. PS Jhund, K Macintyre, CR Simpson Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people Circulation 119 2009 515 523
3. M Shafazand, M Schaufelberger, G Lappas, K Swedberg, A Rosengren Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry Eur Heart J 30 2009 671 678
4. M Gheorghiade, WS Colucci, K Swedberg Beta-blockers in chronic heart failure Circulation 107 2003 1570 1575
5. JE Udelson Ventricular remodeling in heart failure and the effect of beta-blockade Am J Cardiol 93 2004 43B 48B
6. MERIT-HF Study Group Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
7. P Lechat Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial Circulation 103 2001 1428 1433
8. FA McAlister, N Wiebe, JA Ezekowitz, AA Leung, PW Armstrong Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure Ann Intern Med 150 2009 784 794
9. AM Katz The myocardium in congestive heart failure Am J Cardiol 3 1989 12A 16A
10. A Diaz, MG Bourassa, MC Guertin, JC Tardif Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease Eur Heart J 26 2005 967 974
11. L Wilhelmsen, G Berglund, D Elmfeldt The multifactor primary prevention trial in Göteborg, Sweden Eur Heart J 7 1986 279 288
12. K Fox, I Ford, PG Steg, M Tendera, M Robertson, R Ferrari on behalf of the BEAUTIFUL investigators Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial Lancet 372 2008 817 821
13. SJ Pocock, D Wang, MA Pfeffer Predictors of mortality and morbidity in patients with chronic heart failure Eur Heart J 27 2006 65 75
14. G Flannery, R Gehrig-Mills, B Billah, H Krum Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers Am J Cardiol 101 2008 865 869
15. M Komajda, F Follath, K Swedberg The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment Eur Heart J 24 2003 464 474 (Pubitemid 36286188)
16. D DiFrancesco Funny channels in the control of cardiac rhythm and mode of action of selective blockers Pharmacol Res 53 2006 399 406
17. f inhibition with ivabradine: electrophysiological effects and safety Drug Saf 31 2008 95 107
18. K Swedberg, M Komajda, M Bohm, JS Borer, I Ford, L Tavazzi Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the I(f) Inhibitor Ivabradine Trial (SHIFT) Eur J Heart Fail 12 2010 75 81
19. K Swedberg, J Cleland, H Dargie Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Eur Heart J 26 2005 1115 1140
20. F Waagstein, MR Bristow, K Swedberg Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy Lancet 342 1993 1441 1446
21. P de Groote, R Isnard, P Assyag Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey Eur J Heart Fail 9 2007 1205 1211
22. U Dahlstrom, J Hakansson, K Swedberg, A Waldenstrom Adequacy of diagnosis and treatment of chronic heart failure in primary health care in Sweden Eur J Heart Fail 11 2009 92 98
23. JE Blair, F Zannad, MA Konstam Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program J Am Coll Cardiol 52 2008 1640 1648
24. K Fox, I Ford, PG Steg, M Tendera, R Ferrari on behalf of the BEAUTIFUL Investigators Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial Lancet 372 2008 807 816
25. M Packer Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study Circulation 106 2002 2194 2199
26. C Torp-Pedersen, PA Poole-Wilson, K Swedberg Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure - COMET Am Heart J 149 2005 370 376